Blue-sky thinking about blue-light cystoscopy

BJU International

Volumn 104, Issue 7, 2009, Pages 887-889

  Thomas, Kay ^a   O'Brien, Timothy ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Blue light; Photodynamic diagnosis; Transurethral resection bladder tumour

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; MITOMYCIN; 5-AMINOLEVULINIC ACID HEXYL ESTER; PHOTOSENSITIZING AGENT;

BCG VACCINATION; BLADDER TUMOR; BLUE LIGHT; CANCER GRADING; CARCINOMA IN SITU; CYSTOSCOPY; HUMAN; IMMUNOTHERAPY; LASER SURGERY; NOTE; PHOTODYNAMICS; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; TUMOR RECURRENCE; URINE CYTOLOGY; ANALOGS AND DERIVATIVES; DIAGNOSTIC USE; FLUORESCENCE MICROSCOPY; NEOPLASM RECURRENCE, LOCAL; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

AMINOLEVULINIC ACID; CYSTOSCOPY; HUMANS; MICROSCOPY, FLUORESCENCE; NEOPLASM RECURRENCE, LOCAL; PHOTOSENSITIZING AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REOPERATION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 70049108308     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08713.x     Document Type: Note

References (12)

1. Schmidbauer J, Witjes F, Scmeller N, Donat R, Susani M, Marberger M. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004 171 : 135 138
2. Grossman HB, Gomella L, Fradet Y et al. A phase III, multicentre comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007 178 : 62 7
3. Ray ER, Chatterton K, Thomas K, Khan MS, Chandra A, O'Brien TS. Hexaminolevulinate photodynamic diagnosis (HAL PDD) assisted transurethral resection of multifocal recurrent non-muscle invasive bladder cancer. J Endourol 2009 23 : 983 988
4. Ray ER, Chatterton K, Khan MS, Chandra A, O'Brien TS. Hexaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology. BJU Int 2009 103 : 1363 1367
5. Ray ER, Chatterton K, Khan MS et al. Hexaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guerin. BJU Int 2009 (in press)
6. Loidl W, Schmidbauer J, Susani M, Marberger M. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance? Eur Urol 2005 47 : 323 326
7. Schwaibold HE, Sivalingham S, My F, Hartung R. The value of a second transurethral resection for T1 bladder cancer. BJU Int 2006 97 : 1199 1201
8. Bressel M, Kemper K, Stadtler F. Requirements and technique of transurethral resection of bladder carcinoma. Urologe 1969 8 : 73 80
9. Divrik RT, Yildrim U, Zorlu F, Ozen H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumours of the bladder who received intravesical mitomycin: a prospective randomised trial. J Urol 2006 175 : 1641 1644
10. Herr HW. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus calmette-guerin therapy. J Urol 2005 174 : 2134 2137
11. Rodel C, Grabenbauer GG, Kuhn R et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long term results. J Clin Oncol 2002 20 : 3061 3071
12. Mameghan H, Fisher R, Mameghan J, Brook S. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 1995 31 : 247 254